A long-running controversy sparked by the Italian government's decision to fund a clinical trial of an unapproved stem cell therapy may have reached its final chapter. Last week, a panel of experts appointed by the Italian Ministry of Health concluded that the trial of the so-called Stamina method should not move forward.
http://ift.tt/1vLenql
http://ift.tt/1vLenql
No comments:
Post a Comment